Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clerico

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Cardiovascular Surgery|August 1, 1994
Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot studyG Maggi, C Casadio, R Cianci, et al.
Journal of Clinical Pharmacology|November 10, 1998
Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancerS Guadagni, K R Aigner, G Palumbo, et al.
Minerva Medica|September 1, 1991
[Treatment of N2-3 pulmonary carcinoma. Preoperative radio-chemotherapy]O Bertetto, A Boidi Trotti, S Bretti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2001
Interferon-beta dose and efficacy: the OPTIMS studyL Durelli, A Oggero, E Verdun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NabP Barbero, M Bergui, E Versino, et al.
The Journal of Biological Chemistry|April 22, 2017
Key features of an Hsp70 chaperone allosteric landscape revealed by ion-mobility native mass spectrometry and double electron-electron resonanceAlex L Lai, Eugenia M Clerico, Mandy E Blackburn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupT A Splinter, T Sahmoud, J Festen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupM Clavel, J B Vermorken, F Cognetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2007
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosisL Durelli, P Barbero, M Bergui, et al.
International Forum of Allergy & Rhinology|February 19, 2024
Severe epistaxis after posterior nasal nerve ablation requiring surgical intervention: A multi-center case seriesNajm S Khan, Yuki Yoshiyasu, Brian S Wang, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Cardiovascular Surgery|August 1, 1994
Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot studyG Maggi, C Casadio, R Cianci, et al.
Journal of Clinical Pharmacology|November 10, 1998
Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancerS Guadagni, K R Aigner, G Palumbo, et al.
Minerva Medica|September 1, 1991
[Treatment of N2-3 pulmonary carcinoma. Preoperative radio-chemotherapy]O Bertetto, A Boidi Trotti, S Bretti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2001
Interferon-beta dose and efficacy: the OPTIMS studyL Durelli, A Oggero, E Verdun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NabP Barbero, M Bergui, E Versino, et al.
The Journal of Biological Chemistry|April 22, 2017
Key features of an Hsp70 chaperone allosteric landscape revealed by ion-mobility native mass spectrometry and double electron-electron resonanceAlex L Lai, Eugenia M Clerico, Mandy E Blackburn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupT A Splinter, T Sahmoud, J Festen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupM Clavel, J B Vermorken, F Cognetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2007
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosisL Durelli, P Barbero, M Bergui, et al.
International Forum of Allergy & Rhinology|February 19, 2024
Severe epistaxis after posterior nasal nerve ablation requiring surgical intervention: A multi-center case seriesNajm S Khan, Yuki Yoshiyasu, Brian S Wang, et al.
Pageof 7